Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology
批准号:
10456243
负责人:
Joshua A Boyce
金额:
$42.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-07-15 至 2026-04-30
关键词:
3-DimensionalAdultAnatomyAspirinAsthmaAutomobile DrivingCell CommunicationCell CountCell ProliferationCell physiologyCellsCharacteristicsChymaseConsumptionCuesCytokine SignalingDataDevelopmentDiagnosticDinoprostoneDiseaseEffector CellEosinophiliaEpithelialEthicsFibroblastsFunctional disorderGenetic TranscriptionGoalsHealth ExpendituresHeterogeneityHomeostasisHumanIL6ST geneIgEImmuneImmune responseIndividualInterleukin 4 ReceptorInterleukin-6LipidsMapsMediator of activation proteinMolecularMucous MembraneNasal PolypsNoseObstructionOnset of illnessOrganPathogenesisPathway AnalysisPathway interactionsPatientsPharmaceutical PreparationsPhenotypePopulationProliferatingProliferation MarkerReactionRegulationRespiratory DiseaseRespiratory SystemRespiratory Tract DiseasesRoleSignal TransductionStromal CellsSystemTestingTherapeuticTissuesTryptaseTumorigenicityairway obstructionaspirin-exacerbated respiratory diseasebasechronic rhinosinusitiscyclooxygenase 1cytokineimmunopathologyin vivoleukemiamast cellmastocytosisnovelpolyposisprogramsrecruitrespiratorystem cellstherapeutic target
中文摘要
摘要/摘要
本项目的重点是肥大细胞(MC)增殖、异质性和
慢性鼻窦炎合并鼻息肉(CRSwNP)的激活,尤其是在阿司匹林中
急性呼吸道疾病(AERD)。AADCRC目前迭代的研究表明,
典型的肥大细胞亚型表达类胰蛋白酶和糜酶(MCTC)或单独表达类胰蛋白酶(MCT)
新的CD117hiCD38在过渡MC人群中具有丰富的增殖和激活标志。
新的数据表明,成纤维细胞衍生的因子推动了这种增殖的MC群体的出现
循环MC祖细胞和基质细胞与细胞因子(特别是IL-4Rα活性)共谋
细胞因子和IL-33)在相应不同的解剖结构中驱动不同的MC效应功能
鼻腔粘膜的隔室。一种结合功能研究的无监督网络分析
一种新的三维培养系统揭示了MC来源的LIF和LIF之间可能的前馈系统
成纤维细胞来源的IL-6可能促进MC的扩张和激活,并受到IL-4Rα的极大促进
MC和成纤维细胞上的信号转导。该项目结合了假设检验和无偏见的方法
了解巨噬细胞的发育起源,巨噬细胞在T2I中扩张和激活的功能控制,
在此背景下,MC进而影响基质细胞功能的机制。从长远来看,
目标是准确地识别最有责任驱动MC的细胞内在和外在因素
并影响其在呼吸系统T2I的效应功能,以了解局部后果
MC对组织功能的影响,并找出潜在的治疗靶点。目标一号将绘制分子图
循环单核细胞趋化蛋白及其可能的组织后代之间的转变和决定发育的
富含增殖的过渡性MC的起源。目标2将确定成纤维细胞和
内皮祖细胞促进上皮下巨噬细胞和移行巨噬细胞的发育并增强其活化
T2I的设置。目标3将确定基质细胞扩增的MC衍生介质的作用,包括LIF,
在T2I中驱动MC-基质细胞的相互作用。该项目是AADCRC总体目标的组成部分,以及
涉及到与其他两个项目的实质性互动。
英文摘要
Abstract/Summary
This Project focuses on the mechanisms responsible for mast cell (MC) hyperplasia, heterogeneity, and
activation that are characteristic of chronic rhinosinusitis with nasal polyposis (CRSwNP), especially in aspirin
exacerbated respiratory disease (AERD). Studies in the current iteration of this AADCRC suggest that
canonical mast cell subtypes expressing tryptase and chymase (MCTC) or tryptase alone (MCT) emerge from a
novel CD117hiCD38hi transitional MC population that is enriched for markers of proliferation and activation.
New data suggest that fibroblast-derived factors drive the emergence of this proliferating MC population from
circulating MC progenitors (MCp), and that stromal cells conspire with cytokines (particularly IL-4Rα-active
cytokines and IL-33) to drive different MC effector functions in correspondingly different anatomic
compartments of the sinonasal mucosa. An unsupervised network analysis combined with functional studies in
a novel 3-dimensional culture system reveals a likely feed-forward system between MC-derived LIF and
fibroblast-derived IL-6 that may promote MC expansion and activation, and is greatly facilitated by IL-4Rα
signaling at both MCs and fibroblasts. This Project combines hypothesis-testing and unbiased approaches to
understand the developmental origins of MCs, the functional control of MC expansion and activation in T2I,
and the mechanisms by which MCs in turn influence stromal cell function in this context. The long-term overall
goals are to precisely identify the cell-intrinsic and -extrinsic factors most responsible for driving MC
hyperplasia and influencing their effector function in respiratory T2I, to understand the local consequences of
MC hyperplasia in tissue function, and to identify potential therapeutic targets. Aim 1 will map the molecular
transitions between circulating MCp and their putative tissue descendants and determine the developmental
origins of proliferation-enriched transitional MCs. Aim 2 will identify the mechanisms by which fibroblasts and
EpCs facilitate the development of subepithelial MCTC and transitional MCs and potentiate their activation in
the setting of T2I. Aim 3 will determine the role of stromal cell-amplified MC-derived mediators, including LIF,
in driving MC-stromal cell interactions in T2I. The project is integral to the overall goals of the AADCRC, and
involves substantial interactions with the other two Projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Pulmonary Inflammation by Leukotriene E4
-
批准号:10296403
-
项目类别:
-
资助金额:$70.07万
-
财政年份:2021
-
负责人:Joshua A Boyce
-
依托单位:
Control of Pulmonary Inflammation by Leukotriene E4
-
批准号:10468771
-
项目类别:
-
资助金额:$70.07万
-
财政年份:2021
-
负责人:Joshua A Boyce
-
依托单位:
Control of Pulmonary Inflammation by Leukotriene E4
-
批准号:10666460
-
项目类别:
-
资助金额:$70.07万
-
财政年份:2021
-
负责人:Joshua A Boyce
-
依托单位:
Influence of NSAIDs and AERD on the expression and function of ACE2 - implications for SARS-CoV2 severity
-
批准号:10197400
-
项目类别:
-
资助金额:$11.42万
-
财政年份:2020
-
负责人:Joshua A Boyce
-
依托单位:
CysLT and P2Y Receptors in Lung Inflammation
-
批准号:10321255
-
项目类别:
-
资助金额:$53.55万
-
财政年份:2018
-
负责人:Joshua A Boyce
-
依托单位:
CysLT and P2Y Receptors in Lung Inflammation
-
批准号:10083690
-
项目类别:
-
资助金额:$53.55万
-
财政年份:2018
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Hypersensitivity
-
批准号:10296672
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2017
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Hypersensitivity
-
批准号:10062848
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2017
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Hypersensitivity
-
批准号:10517922
-
项目类别:
-
资助金额:$65.65万
-
财政年份:2017
-
负责人:Joshua A Boyce
-
依托单位:
Characterization of a Novel Growth and Survival Factor for Human Mast Cells
-
批准号:8977481
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2014
-
负责人:Joshua A Boyce
-
依托单位:
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD
-
批准号:8915315
-
项目类别:
-
资助金额:$14.81万
-
财政年份:2014
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
-
批准号:9061003
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2013
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
-
批准号:8476459
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2013
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
-
批准号:8675938
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2013
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
-
批准号:10456240
-
项目类别:
-
资助金额:$153.56万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
-
批准号:9294916
-
项目类别:
-
资助金额:$197.9万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
-
批准号:9973135
-
项目类别:
-
资助金额:$154.34万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
-
批准号:10626842
-
项目类别:
-
资助金额:$153.56万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
-
批准号:10260780
-
项目类别:
-
资助金额:$153.51万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*
-
批准号:8502613
-
项目类别:
-
资助金额:$228.0万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
海外基金